Onconic Therapeutics Inc. clinical trials
A subsidiary of Jeil Pharmaceutical Co., Ltd.
The registry lists 19 studies whose lead sponsor is Onconic Therapeutics Inc.. 9 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 15, 2026.
Where
- Korea, Republic of
- 16
Registry sponsor names on this page
- Onconic Therapeutics Inc.19 studies
Something wrong with this grouping? Tell us on the Jeil Pharmaceutical Co., Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 19 of 19. All Jeil Pharmaceutical Co., Ltd. studies →
- Efficacy and Safety of JP-1366-based Triple Therapy in Helicobacter Pylori-positive SubjectsNot yet recruitingNCT07875933Phase 3
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 as Maintenance Therapy in Subjects With Healed Erosive EsophagitisNot yet recruitingNCT07732075Phase 3
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy Male ParticipantsNot yet recruitingNCT07570186Phase 1
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic CancerRecruitingNCT05257993Phase 1/2
Sponsor listed in the registry: Onconic Therapeutics Inc.
- To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as Maintenance Therapy in Relapsed Ovarian CancerNot yet recruitingNCT07370818Phase 2
Sponsor listed in the registry: Onconic Therapeutics Inc.
- To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric CancerNot yet recruitingNCT07364422Phase 1/2
Sponsor listed in the registry: Onconic Therapeutics Inc.
- to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and ApixabanRecruitingNCT07265466Phase 1
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux DiseaseNot yet recruitingNCT07160790Phase 3
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic UlcersRecruitingNCT06439563Phase 3
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Phase 1 Study of JLP-2302 and JP-1366: PK and Safety in Healthy VolunteersCompletedNCT07181538Phase 1
Sponsor listed in the registry: Onconic Therapeutics Inc.
- JP-1366 20mg Versus Esomeprazole 40mg in Patients With Erosive EsophagitisCompletedNCT05443984Phase 3
Sponsor listed in the registry: Onconic Therapeutics Inc.
- A Study to Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP InhibitorActive, not recruitingNCT05475184Phase 2
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric UlcerCompletedNCT05448001Phase 3
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Clinical Trial to Evaluate Food-Effects on Pharmacokinetics and Pharmacodynamics of Oral Single Dose of JP-1366 Tablet in Healthy VolunteersCompletedNCT05712681Phase 1
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Clinical Trial to Evaluate the Safety and Pharmacokinetics of JP-1366 in Healthy Adult VolunteersCompletedNCT05814809Phase 1
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux DiseaseCompletedNCT04282954Phase 2
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Compare Pharmacokinetics and Safety of JP-1366 Between Korean and CaucasianCompletedNCT05181124Phase 1
Sponsor listed in the registry: Onconic Therapeutics Inc.
- A Study of NOV140201 (JPI-547) in Subject With Advanced Solid TumorsCompletedNCT04335604Phase 1
Sponsor listed in the registry: Onconic Therapeutics Inc.
- Drug-drug Interactions and Safety Among JP-1366, Amoxicillin, and Clarithromycin in Healthy VolunteersCompletedNCT05194046Phase 1
Sponsor listed in the registry: Onconic Therapeutics Inc.